Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-06 2:49 pm Sale |
2022-12-30 | 13G | Apellis Pharmaceuticals, Inc. APLS |
WELLINGTON MANAGEMENT CO LLP | 8,820,398 7.980% |
-3,657,855 (-29.31%) |
Filing History |
| 2023-01-31 5:52 pm Purchase |
2022-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS |
BLACKROCK INC BLK |
7,704,194 7.000% |
1,838,482 (+31.34%) |
Filing History |
| 2022-02-14 4:05 pm Purchase |
2021-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS |
Morningside Venture Investments Limited | 12,806,342 13.200% |
250,000 (+1.99%) |
Filing History |
| 2022-02-14 4:04 pm Sale |
2021-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS |
HHLR Advisors, Ltd. | 0 0.000% |
-5,028,289 (Position Closed) |
Filing History |
| 2022-02-14 2:34 pm Purchase |
2021-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS |
PRICE T ROWE ASSOCIATES INC | 5,307,486 5.400% |
5,307,486 (New Position) |
Filing History |
| 2022-02-11 10:04 am Purchase |
2021-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS |
AVORO CAPITAL ADVISORS LLC | 8,555,555 8.900% |
8,555,555 (New Position) |
Filing History |
| 2022-02-09 3:24 pm Purchase |
2021-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS |
The Vanguard Group | 7,917,099 8.140% |
2,375,274 (+42.86%) |
Filing History |
| 2022-02-04 09:15 am Purchase |
2021-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS |
WELLINGTON MANAGEMENT CO LLP | 12,478,253 12.830% |
1,900,333 (+17.97%) |
Filing History |
| 2022-02-03 4:41 pm Sale |
2021-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS |
BLACKROCK INC BLK |
5,865,712 6.100% |
-149,236 (-2.48%) |
Filing History |
| 2021-02-16 4:17 pm Purchase |
2020-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS |
Morningside Venture Investments Limited | 12,556,342 15.800% |
540,540 (+4.50%) |
Filing History |
| 2021-02-16 4:09 pm Purchase |
2020-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS |
HHLR Advisors, Ltd. | 5,028,289 6.600% |
350,000 (+7.48%) |
Filing History |
| 2021-02-10 10:30 am Purchase |
2020-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS |
The Vanguard Group | 5,541,825 7.320% |
5,541,825 (New Position) |
Filing History |
| 2021-02-05 07:51 am Purchase |
2020-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS |
BLACKROCK INC BLK |
6,014,948 7.900% |
1,257,443 (+26.43%) |
Filing History |
| 2021-02-03 1:33 pm Purchase |
2020-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS |
WELLINGTON MANAGEMENT CO LLP | 10,577,920 13.970% |
295,290 (+2.87%) |
Filing History |